Blog

  • Does RTX’s Latest 13% Surge Signal Room for Growth or Market Hype in 2025?

    Does RTX’s Latest 13% Surge Signal Room for Growth or Market Hype in 2025?

    Trying to decide what to do with RTX stock? You’re not alone. Whether you’re a long-term investor or just keeping an eye out for the next big swing, RTX has definitely captured attention with its impressive performance. Over the past year, the stock has jumped a generous 45.6%, with a stunning 54.0% return year-to-date. That momentum is not slowing down. RTX surged 13.1% this past week and 9.4% over the last 30 days. If you zoom out even further, the five-year return clocks in at a jaw-dropping 270.1%. High numbers like these always get people talking about growth potential, but they also raise questions about whether the market is getting ahead of itself.

    Recent headlines have given RTX’s latest rally some extra fuel. The company’s strategic moves in the aerospace and defense sectors have reaffirmed to investors that it is still a major player, drawing attention for positive developments in technology and contracts. There have not been any dramatic surprises to shake confidence, but market watchers are clearly renewing their optimism about RTX’s prospects amid industry shifts.

    With all this excitement, you are probably wondering about RTX’s true value. Our quick scan of valuation checks shows that RTX is undervalued in just 1 out of 6 criteria, which is a value score of 1. At first glance, it does not exactly suggest a bargain. But as we break down what is behind those numbers, you will see the bigger picture. Next, let’s dig into the different ways analysts measure a company’s value, and stick around as we also explore a powerful alternative for understanding RTX’s valuation at the end of the article.

    RTX scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

    The Discounted Cash Flow (DCF) model estimates a company’s value by projecting its future cash flows and discounting them back to today’s dollars. This method gives investors a sense of what the business could fundamentally be worth if those cash flows materialize as expected.

    RTX’s most recent reported Free Cash Flow is $4.47 billion. According to analyst forecasts, RTX’s annual free cash flow is projected to rise significantly over the coming years, with an estimated $10.77 billion expected by the end of 2029. While analyst estimates are available for the next few years, projections for the later years are modeled based on historic growth and trends by Simply Wall St, so precision decreases further out as a result.

    After factoring in these projections and discounting future values, RTX’s intrinsic value is calculated at $135.85 per share. However, the model indicates RTX stock currently trades at a 31.5% premium to its DCF-calculated value. This means it is considered overvalued according to this approach.

    Continue Reading

  • Will Rising Self-Mined Bitcoin Output and AI Demand Shift Bitdeer Technologies Group’s (BTDR) Long-Term Narrative?

    Will Rising Self-Mined Bitcoin Output and AI Demand Shift Bitdeer Technologies Group’s (BTDR) Long-Term Narrative?

    • Bitdeer Technologies Group recently announced unaudited operating results for September 2025, reporting that it mined 452 Bitcoins, a rise of approximately 20.5% from August, driven by increased self-mining capacity following the energization of SEALMINERs.

    • This operating update comes as sector optimism grows, with attention on data center demand and AI-driven computing partnerships possibly benefiting industry players like Bitdeer.

    • With Bitdeer’s self-mining gains and momentum in high-performance computing demand, we’ll assess how these developments affect the company’s broader investment narrative.

    AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.

    To be a shareholder in Bitdeer Technologies Group, one needs to believe in the company’s ability to scale its self-mining capacity and commercialize its proprietary ASIC technology amid rising demand for high-performance computing. The recent news of a 20.5% increase in Bitcoin mined boosts short-term confidence, but it does not materially change the core catalyst, growing revenue and margins from ASIC commercialization, nor does it reduce the key risk of persistent losses and high operating expenses.

    The September operating update most directly ties to the recent launch of the SEALMINER A3 series, which underpins Bitdeer’s growth in self-mining hashrate and supports the narrative around technological advancement improving capital efficiency. As Bitdeer pushes further into ASIC development and ramp-up, this connection highlights how delivering on technical improvements remains intertwined with realizing forecast revenue growth and addressing margin pressures.

    However, despite these production gains, investors should not overlook the risk stemming from high operating expenses and ongoing losses, especially if future ASIC sales do not keep pace with growing costs…

    Read the full narrative on Bitdeer Technologies Group (it’s free!)

    Bitdeer Technologies Group’s narrative projects $1.8 billion revenue and $343.9 million earnings by 2028. This requires 71.6% yearly revenue growth and a $664.2 million increase in earnings from the current -$320.3 million.

    Uncover how Bitdeer Technologies Group’s forecasts yield a $28.05 fair value, a 21% upside to its current price.

    BTDR Community Fair Values as at Oct 2025

    Seven individual fair value estimates from the Simply Wall St Community for Bitdeer span US$18.55 to US$324.62, highlighting a broad spectrum of conviction. With high expenses a persistent concern, you can explore how fellow investors weigh these risks before forming your outlook.

    Explore 7 other fair value estimates on Bitdeer Technologies Group – why the stock might be worth 20% less than the current price!

    Disagree with existing narratives? Create your own in under 3 minutes – extraordinary investment returns rarely come from following the herd.

    Every day counts. These free picks are already gaining attention. See them before the crowd does:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include BTDR.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Gauging Valuation After Recent Modest Gains in Autonomous Vehicle Tech

    Gauging Valuation After Recent Modest Gains in Autonomous Vehicle Tech

    Aurora Innovation (AUR) shares have edged slightly higher recently, following a modest uptick of about 2% in the last day and smaller gains over the past week. Investors seem to be weighing the company’s performance during the month, as Aurora continues its work in autonomous vehicle technology.

    See our latest analysis for Aurora Innovation.

    Zooming out, Aurora Innovation’s 1-year share price return is still down double digits, while its three-year total shareholder return remains notably positive. After a recent stretch of modest gains, momentum is still searching for its footing as investors gauge the company’s long-term roadmap and evolving risk profile.

    If Aurora’s recent moves have you reflecting on shifts across the sector, now is the perfect time to explore innovation on a broader scale through the See the full list for free.

    With shares trading well below analyst price targets and impressive long-term gains in the rearview, investors now face a critical question: Is Aurora a bargain poised for growth, or is the market already factoring in its future potential?

    At a price-to-book ratio of 4.8x, Aurora Innovation trades below its peer average of 5.9x based on this valuation measure. This suggests the stock is relatively more attractively priced compared to similar companies. With the last close at $5.15, this indicates the market is discounting Aurora relative to its book value more than its immediate peer group.

    The price-to-book ratio compares a company’s market value to its net asset value. This metric is particularly relevant for asset-light and high-growth sectors like software and autonomous vehicles. For Aurora, this ratio reflects what investors are willing to pay for the company’s equity compared to the book value recorded on its balance sheet.

    This valuation suggests investors may be skeptical about Aurora’s path to profitability or are discounting near-term challenges, despite the sector’s broader appetite for growth. However, the company’s price-to-book still remains higher than the US Software industry average of 4x. This signals the market may still be assigning a premium for its technology or future prospects relative to the average US software company, though less so compared to its closest peers.

    See what the numbers say about this price — find out in our valuation breakdown.

    Result: Price-to-Book of 4.8x (UNDERVALUED compared to peers)

    However, continued net losses and uncertainty around the company’s path to profitability remain challenges that could weigh on future share performance.

    Find out about the key risks to this Aurora Innovation narrative.

    While the price-to-book ratio offers one angle on Aurora’s value, the SWS DCF model provides a different perspective. According to our DCF analysis, Aurora shares are currently trading about 37.8% below our estimate of their fair value. This suggests a considerable undervaluation if you believe the model’s assumptions.

    Look into how the SWS DCF model arrives at its fair value.

    AUR Discounted Cash Flow as at Oct 2025

    Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Aurora Innovation for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

    If you see the story differently or want to dig into the numbers yourself, you can craft your own take in just a few minutes with Do it your way.

    A great starting point for your Aurora Innovation research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

    Smart investors never settle for just one option. Supercharge your research by tapping into untapped potential, income opportunities, and innovation leaders before the crowd moves in.

    • Uncover companies reshaping artificial intelligence and automation by reviewing these 27 AI penny stocks. These firms are disrupting industries with bold advancements and new business models.

    • Generate steady income streams by assessing these 17 dividend stocks with yields > 3%. These options offer attractive yields and strong fundamentals for long-term growth.

    • Capitalize on unique trends in decentralized finance by evaluating these 80 cryptocurrency and blockchain stocks. These selections are positioned at the frontier of digital finance and next-generation payment solutions.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include AUR.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Integrating GLP-1 Therapy, Advancing CSU Care, and Expanding Access

    Integrating GLP-1 Therapy, Advancing CSU Care, and Expanding Access

    GLP-1 Receptor Agonists and Psoriasis

    According to Serota, dermatologists should recognize obesity as a chronic inflammatory condition that often exacerbates inflammatory skin diseases such as psoriasis. “If your patient is overweight or obese,…

    Continue Reading

  • Scientists finally explain why the Sun’s corona burns millions of degrees hotter than its surface

    Scientists finally explain why the Sun’s corona burns millions of degrees hotter than its surface

    For decades, scientists have wondered how the Sun’s outer atmosphere — the corona — burns millions of degrees hotter than its surface. A new study led by Northumbria University physicist Richard Morton offers a major clue: the Sun’s heat…

    Continue Reading

  • World’s First Private Space Station, Haven-1 sets world record

    World’s First Private Space Station, Haven-1 sets world record

    Long Beach, California, United State–Haven-1, developed by the American company
    Vast, a single-module station designed to launch in May 2026 on a SpaceX Falcon 9 rocket and will support up to four astronauts for short-duration missions,…

    Continue Reading

  • Perioperative Antibiotic Administration Review: An Analysis of Outpatient Surgeries at OhioHealth Doctors Hospital

    Perioperative Antibiotic Administration Review: An Analysis of Outpatient Surgeries at OhioHealth Doctors Hospital

    Continue Reading

  • Pneumococcal Conjugate Vaccines Reduces Incidence of Pneumonia for Children 2 Years and Under

    Pneumococcal Conjugate Vaccines Reduces Incidence of Pneumonia for Children 2 Years and Under

    Pneumococcal conjugate vaccines (PCV) reduced the incidence of pneumonia and improved levels of IgG antibodies in pediatric patients, according to results of a study published in Frontiers in Pediatrics. However, there is a lack of data on…

    Continue Reading

  • Google’s Gemini will now generate presentations for you

    Google’s Gemini will now generate presentations for you

    Google is rolling out out a new feature for Gemini’s Canvas, the free interactive workspace inside the AI chatbot’s app, meant for students and employees who need to create presentations. Gemini is now capable of generating slides with just a…

    Continue Reading

  • This New York City Penthouse Feels Like a Boutique Hotel—and Fits 20 for Thanksgiving

    This New York City Penthouse Feels Like a Boutique Hotel—and Fits 20 for Thanksgiving

    When a far-flung family decided to create a pied-à-terre in downtown Manhattan where they could all gather, they envisioned something warm and welcoming but with a definite New York state of mind. It also had to be big enough to accommodate…

    Continue Reading